Drug
APG777
APG777 is a pharmaceutical drug with 4 clinical trials. Currently 4 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
4(100%)
Phase Distribution
Ph phase_2
2
50%
Ph phase_1
2
50%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Active, not recruiting3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
4
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 22 (50.0%)
Trials by Status
active_not_recruiting375%
recruiting125%
Recent Activity
4 active trials
Showing 4 of 4
recruitingphase_2
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
NCT07003425
active_not_recruitingphase_2
A Study Evaluating APG777 in Atopic Dermatitis
NCT06395948
active_not_recruitingphase_1
An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis
NCT07027527
active_not_recruitingphase_1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma
NCT06920901
Clinical Trials (4)
Showing 4 of 4 trials
NCT07003425Phase 2
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
NCT06395948Phase 2
A Study Evaluating APG777 in Atopic Dermatitis
NCT07027527Phase 1
An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis
NCT06920901Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4